Mark W. Harty
- Molecular Biology
- Immunology top 10%
- Surgery
- Oncology
- Rehabilitation top 5%
- Co-authors
- Anthony L. MescherMichael W. KingAnton W. NeffMegan SykesD. A. PearsonThomas F. TracyElaine PapaVarghese Abraham
- Topics
- Liver physiology and pathology (4 papers)Pediatric Hepatobiliary Diseases and Treatments (3 papers)Organ Transplantation Techniques and Outcomes (3 papers)
- Cited by
- RehabilitationHepatologyImmunology
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Mark W. Harty
20 papers receiving 964 citations
Peers
Comparison fields: 5 of 101
- Molecular Biology 301
- Immunology 280
- Surgery 151
- Oncology 118
- Rehabilitation 112
Countries citing papers authored by Mark W. Harty
This map shows the geographic impact of Mark W. Harty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Harty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Harty more than expected).
Fields of papers citing papers by Mark W. Harty
This network shows the impact of papers produced by Mark W. Harty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Harty. The network helps show where Mark W. Harty may publish in the future.
Co-authorship network of co-authors of Mark W. Harty
This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Harty. A scholar is included among the top collaborators of Mark W. Harty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Harty. Mark W. Harty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 51 | |
| 3 | 94 | |
| 4 | 6 | |
| 5 | 11 | |
| 6 | 33 | |
| 7 | 32 | |
| 8 | 76 | |
| 9 | 95 | |
| 10 | 37 | |
| 11 | 37 | |
| 12 | 196 | |
| 13 | 39 | |
| 14 | 29 | |
| 15 | 3 | |
| 16 | 49 | |
| 17 | 9 | |
| 18 | Selective inhibition of CD4 graft-versus-host activity in IL-2-treated mice. | 3 |
| 19 | 87 | |
| 20 | 94 |
About Mark W. Harty
Mark W. Harty is a scholar working on Hepatology, Developmental Biology and Rehabilitation, having authored 20 papers that have together received 982 indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers) and Organ Transplantation Techniques and Outcomes (3 papers). The work is most often cited by research in Rehabilitation (112 citations), Hepatology (111 citations) and Immunology (280 citations). Mark W. Harty has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Anthony L. Mescher, Michael W. King, Anton W. Neff, Megan Sykes, D. A. Pearson, Thomas F. Tracy, Elaine Papa, Varghese Abraham, Stephan Gehring and Gregory L. Szot. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.